Trastuzumab Completed Phase N/A Trials for Breast Cancer Treatment

IndicationsStatusPurposePhase
CompletedTreatmentNot Available
clinicaltrials.gov IdentifierTitleDrugs
NCT00535509Phase II Trial of Neoadjuvant[FEC100]/Cisplatin-Docetaxel ± Trastuzumab in Women With Over Expressed or Amplified Her2/Neu With Locally Advanced Breast Cancer
NCT01048099Use of PRO Onc Assay to Assess HER2 in Patients With Metastatic Breast Cancer
NCT00896376Trastuzumab in Treating Women With Metastatic Breast Cancer